Health tech startups vie for a piece of drug supply chain
A TECH TWIST ON DRUG BENEFITS: Can a group of health tech startups disrupt the world of pharmacy benefit managers and seize part of a market forecast to be worth as much as $700 billion by the middle of the decade?
Companies such as Capital Rx, WithMe Health and Navitus see an opening, and are using high tech dashboards and data mining in a bid to supplant industry giants, who now manage drug benefits for health insurers, employers and other payers.
These challengers hope to capitalize on the growing scrutiny of PBMs’ role in health spending — especially the practice of “spread pricing,” in which companies charge payers more than they reimburse pharmacies for certain drugs, and pocket the difference.
Read more by clicking the link to the full article below.

MORE ABOUT DAVID
David Fields is the President and CEO at Navitus Health Solutions. He provides enterprise leadership and strategic direction for Navitus, collaborating with the executive management team to maintain Navitus strategic plan and to develop and direct its goals, policies and execution. David has held leadership positions on a number of boards, including the American Heart Association, American Red Cross, Labor-Management Council and the National Conference of Christians and Jews.
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
Examining Trends that Drive Informed Decisions
Now Available: 8th Annual Drug Trend Report
See the latest results and access industry insights you need to navigate current trend drivers.